189 related articles for article (PubMed ID: 25858143)
1. SOCS2 Controls Proliferation and Stemness of Hematopoietic Cells under Stress Conditions and Its Deregulation Marks Unfavorable Acute Leukemias.
Vitali C; Bassani C; Chiodoni C; Fellini E; Guarnotta C; Miotti S; Sangaletti S; Fuligni F; De Cecco L; Piccaluga PP; Colombo MP; Tripodo C
Cancer Res; 2015 Jun; 75(11):2387-99. PubMed ID: 25858143
[TBL] [Abstract][Full Text] [Related]
2. The Wilms' tumor gene WT1-GFP knock-in mouse reveals the dynamic regulation of WT1 expression in normal and leukemic hematopoiesis.
Hosen N; Shirakata T; Nishida S; Yanagihara M; Tsuboi A; Kawakami M; Oji Y; Oka Y; Okabe M; Tan B; Sugiyama H; Weissman IL
Leukemia; 2007 Aug; 21(8):1783-91. PubMed ID: 17525726
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow connexin-43 expression is critical for hematopoietic regeneration after chemotherapy.
Presley CA; Lee AW; Kastl B; Igbinosa I; Yamada Y; Fishman GI; Gutstein DE; Cancelas JA
Cell Commun Adhes; 2005; 12(5-6):307-17. PubMed ID: 16531325
[TBL] [Abstract][Full Text] [Related]
4. SOCS2 is dispensable for BCR/ABL1-induced chronic myeloid leukemia-like disease and for normal hematopoietic stem cell function.
Hansen N; Ågerstam H; Wahlestedt M; Landberg N; Askmyr M; Ehinger M; Rissler M; Lilljebjörn H; Johnels P; Ishiko J; Melo JV; Alexander WS; Bryder D; Järås M; Fioretos T
Leukemia; 2013 Jan; 27(1):130-5. PubMed ID: 22824785
[TBL] [Abstract][Full Text] [Related]
5. Constitutive activation of Flt3 and STAT5A enhances self-renewal and alters differentiation of hematopoietic stem cells.
Moore MA; Dorn DC; Schuringa JJ; Chung KY; Morrone G
Exp Hematol; 2007 Apr; 35(4 Suppl 1):105-16. PubMed ID: 17379095
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic downregulation of Socs2 contributes to mutant N-Ras-mediated hematopoietic dysregulation.
Jin X; Ng V; Zhao M; Liu L; Higashimoto T; Lee ZH; Chung J; Chen V; Ney G; Kandarpa M; Talpaz M; Li Q
Dis Model Mech; 2022 May; 15(5):. PubMed ID: 35352806
[TBL] [Abstract][Full Text] [Related]
7. Biological effects of T315I-mutated BCR-ABL in an embryonic stem cell-derived hematopoiesis model.
Melkus M; Bennaceur-Griscelli A; Valogne Y; Flamant S; Chomel JC; Sorel N; Bonnet ML; Deininger MW; Mitjavila-Garcia MT; Turhan AG
Exp Hematol; 2013 Apr; 41(4):335-45.e3. PubMed ID: 23287417
[TBL] [Abstract][Full Text] [Related]
8. The INK4-ARF (CDKN2A/B) locus in hematopoiesis and BCR-ABL-induced leukemias.
Williams RT; Sherr CJ
Cold Spring Harb Symp Quant Biol; 2008; 73():461-7. PubMed ID: 19028987
[TBL] [Abstract][Full Text] [Related]
9. Differential Hox expression in murine embryonic stem cell models of normal and malignant hematopoiesis.
Wheadon H; Ramsey JM; Dobbin E; Dickson GJ; Corrigan PM; Freeburn RW; Thompson A
Stem Cells Dev; 2011 Aug; 20(8):1465-76. PubMed ID: 21083428
[TBL] [Abstract][Full Text] [Related]
10. Estrogen signaling selectively induces apoptosis of hematopoietic progenitors and myeloid neoplasms without harming steady-state hematopoiesis.
Sánchez-Aguilera A; Arranz L; Martín-Pérez D; García-García A; Stavropoulou V; Kubovcakova L; Isern J; Martín-Salamanca S; Langa X; Skoda RC; Schwaller J; Méndez-Ferrer S
Cell Stem Cell; 2014 Dec; 15(6):791-804. PubMed ID: 25479752
[TBL] [Abstract][Full Text] [Related]
11. [Role of peptide regulatory factors in the proliferation of leukemic blasts].
Tabilio A; Falzetti F; Mannoni P; Martelli MF
Haematologica; 1991 Jun; 76 Suppl 3():85-92. PubMed ID: 1752546
[No Abstract] [Full Text] [Related]
12. Differentiation primary response genes and proto-oncogenes as positive and negative regulators of terminal hematopoietic cell differentiation.
Liebermann DA; Hoffman B
Stem Cells; 1994 Jul; 12(4):352-69. PubMed ID: 7951003
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow neoplastic niche in leukemia.
Azizidoost S; Babashah S; Rahim F; Shahjahani M; Saki N
Hematology; 2014 Jun; 19(4):232-8. PubMed ID: 23905984
[TBL] [Abstract][Full Text] [Related]
14. Shp-2 heterozygous hematopoietic stem cells have deficient repopulating ability due to diminished self-renewal.
Chan RJ; Li Y; Hass MN; Walter A; Voorhorst CS; Shelley WC; Yang Z; Orschell CM; Yoder MC
Exp Hematol; 2006 Sep; 34(9):1230-9. PubMed ID: 16939816
[TBL] [Abstract][Full Text] [Related]
15. High expression of two diverged homeobox genes, HB24 and HB9, in acute leukemias: molecular markers of hematopoietic cell immaturity.
Deguchi Y; Yamanaka Y; Theodossiou C; Najfeld V; Kehrl JH
Leukemia; 1993 Mar; 7(3):446-51. PubMed ID: 7680402
[TBL] [Abstract][Full Text] [Related]
16. Multilevel targeting of hematopoietic stem cell self-renewal, differentiation and apoptosis for leukemia therapy.
Tsiftsoglou AS; Bonovolias ID; Tsiftsoglou SA
Pharmacol Ther; 2009 Jun; 122(3):264-80. PubMed ID: 19306896
[TBL] [Abstract][Full Text] [Related]
17. SOCS2: inhibitor of JAK2V617F-mediated signal transduction.
Quentmeier H; Geffers R; Jost E; Macleod RA; Nagel S; Röhrs S; Romani J; Scherr M; Zaborski M; Drexler HG
Leukemia; 2008 Dec; 22(12):2169-75. PubMed ID: 18769447
[TBL] [Abstract][Full Text] [Related]
18. Lhx2 expression in hematopoietic progenitor/stem cells in vivo causes a chronic myeloproliferative disorder and altered globin expression.
Richter K; Pinto do O P; Hägglund AC; Wahlin A; Carlsson L
Haematologica; 2003 Dec; 88(12):1336-47. PubMed ID: 14687986
[TBL] [Abstract][Full Text] [Related]
19. MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors.
Huntly BJ; Shigematsu H; Deguchi K; Lee BH; Mizuno S; Duclos N; Rowan R; Amaral S; Curley D; Williams IR; Akashi K; Gilliland DG
Cancer Cell; 2004 Dec; 6(6):587-96. PubMed ID: 15607963
[TBL] [Abstract][Full Text] [Related]
20. Megakaryocytopoiesis in vitro: from the stem cells' perspective.
Cardier JE; Foster DC; Lok S; Jacobsen SE; Murphy MJ
Stem Cells; 1996; 14 Suppl 1():163-72. PubMed ID: 11012217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
